Cargando…

Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis

SIMPLE SUMMARY: Our study aimed to apply a quantitative method based on mRNA counting as nCounter (NanoString Technologies, Inc). This method can obtain precise and accurate measures of RNA expression compared to RT-PCR, and which might represent an alternative to the NGS-genomic/transcriptomic prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Beltran, Antonio, Blanca, Ana, Cimadamore, Alessia, Gogna, Rajan, Montironi, Rodolfo, Cheng, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583679/ https://www.ncbi.nlm.nih.gov/pubmed/34771663 http://dx.doi.org/10.3390/cancers13215500

Ejemplares similares

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
por: Blanca, Ana, et al.
Publicado: (2023)

Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies
por: Ricci, Alessia Andrea, et al.
Publicado: (2023)

NanoString Technology for Human Papillomavirus Typing
por: Rajeevan, Mangalathu S., et al.
Publicado: (2021)

NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma
por: Ahmed, Atif A., et al.
Publicado: (2022)

Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology
por: Pedrosa, L., et al.
Publicado: (2023)

News in the classification of WHO 2022 bladder tumors
por: Raspollini, Maria Rosaria, et al.
Publicado: (2023)

Development and validation of a NanoString BASE47 bladder cancer gene classifier
por: Kardos, Jordan, et al.
Publicado: (2020)

Easy NanoString nCounter data analysis with the NanoTube
por: Class, Caleb A, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

T1 bladder carcinoma with variant histology: pathological features and clinical significance
por: Lopez-Beltran, Antonio, et al.
Publicado: (2022)

Comparative studies of two generations of NanoString nCounter System
por: Yu, Lianbo, et al.
Publicado: (2019)

Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2022)

Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter
por: Chen, Yen-Jen, et al.
Publicado: (2021)

Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods
por: Kim, Joo Whan, et al.
Publicado: (2022)

NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data
por: Waggott, Daryl, et al.
Publicado: (2012)

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter
por: Bianconi, Maristella, et al.
Publicado: (2019)

NanoString-based breast cancer risk prediction for women with sclerosing adenosis
por: Winham, Stacey J., et al.
Publicado: (2017)

NACHO: an R package for quality control of NanoString nCounter data
por: Canouil, Mickaël, et al.
Publicado: (2019)

NanoStriDE: normalization and differential expression analysis of NanoString nCounter data
por: Brumbaugh, Christopher D, et al.
Publicado: (2011)

A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform
por: Zhang, Wei, et al.
Publicado: (2021)

NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data
por: Wang, Hong, et al.
Publicado: (2016)

Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis
por: Chitikova, Zhanna, et al.
Publicado: (2015)

Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
por: Evangelista, Adriane F., et al.
Publicado: (2017)

Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies
por: Varol, Hilal, et al.
Publicado: (2022)

Forensic Body Fluid Identification by Analysis of Multiple RNA Markers Using NanoString Technology
por: Park, Jong-Lyul, et al.
Publicado: (2013)

Diagnostic yield of NanoString nCounter FusionPlex profiling in soft tissue tumors
por: Song, Wangzhao, et al.
Publicado: (2020)

Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses
por: D’Angelo, Alberto, et al.
Publicado: (2023)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Lesson from the COVID-19 pandemic: pathologists need to build their confidence on working in a digital microscopy environment
por: Montironi, Rodolfo, et al.
Publicado: (2021)

nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)
por: Cesano, Alessandra
Publicado: (2015)

NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer
por: Das, Kakoli, et al.
Publicado: (2016)

Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString
por: Brocato, Rebecca L., et al.
Publicado: (2021)

Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients
por: Novaes, Lázaro Antonio Campanha, et al.
Publicado: (2021)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4si0bqgsfdv1o3lccdfg8prjhi